An interventional study of PRP injection in Infertility, sponsored by Hadassah Medical Organization. Status unknown at 1 site in Israel. Open to female participants aged 18 Years to 54 Years. Per ClinicalTrials.gov, last updated 2016-11-25.
Sponsored by Hadassah Medical Organization · Not applicable, Interventional, and Treatment
Platelet-rich plasma (PRP) may promote the endometrial growth and improve pregnancy outcome of patients with thin endometrium undergoing ART treatments.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's planned enrollment of 50 is below the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →Hadassah Medical Organization is the lead sponsor of 659 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: PRP injection
autologous intrauterine infusion of PRP
endometrial thickness >7mm
Time frame: 1 month
Positive serum pregnancy test
Time frame: 14 days post embryo transfer
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hadassah Medical Organization